Clara François
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Clara François has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin De Becker
AZ Sint-Jan Brugge AV, Bruges Hospital, Bruges, Belgium
5 shared publications - Jean-Benoît le Polain de Waroux
Department of Cardiology, AZ Sint-Jan Brugge AV, Bruges, Belgium (E.D.C., E.C., J.-B.l.P.d.W., J.V.d.H., I.B.).
4 shared publications - Maarten A. J. De Smet
Department of Electrophysiology, AZ Sint-Jan Hospital, Bruges, Belgium (M.D., M.D.S., J.M., M.E.H., B.D.B., C.F., R.T., J.-B.L.P.d.W., S.K.).
4 shared publications - Mattias Duytschaever
Department of Cardiology, AZ Sint-Jan Hospital, Bruges, Belgium
4 shared publications - Rene Tavernier
Cardiology Department, AZ Sint-Jan Brugge , Ruddershove 10, Bruges 8000
4 shared publications - Sebastien Knecht
AZ Sint-Jan Bruges, Belgium (S.K.).
4 shared publications
Latest Publications
- 23 May 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (8) , 1733-1742
Prospective Evaluation of Superior Vena Cava Isolation as an Adjunct to Pulmonary Vein Re‐Isolation During Paroxysmal Atrial Fibrillation Repeat Procedures
Background: The superior vena cava (SVC) is a prominent non‐pulmonary vein trigger of atrial fibrillation (AF). Its isolation has been shown to be effective in paroxysmal AF (PAF) originating from SVC. Objective: In this study, focusing on repeat procedures for recurrent PAF post‐PVI, we aimed to evaluate the added value of empirical SVC isolation to PV antral re‐isolation, when at least one PV reconnection is demonstrated. Methods: Patients with recurrent PAF referred for redo procedures, and exhibiting PV reconnection, were randomly assigned to undergo either PVI alone (group 1) or PVI and SVC isolation (group 2). The primary outcome was the recurrence rate at 1‐year while procedural time, fluoroscopy time, complications rate, and the presence of scar during LA mapping were secondary outcomes. Results: Eighty‐two patients were randomized in the study (39 in group 1 and 43 in group 2). The median age was 65 ± 9 in group 1 and 62 ± 11 in group 2 ( p = 0.3). The time from first AF episode to the repeat procedure was 76 and 52 months, respectively ( p = 0.7). 31 patients in group 1 and 35 patients in group 2 had more than one reconnected vein. There were no significant differences in procedural and fluoroscopy times between groups. At 12‐months, freedom from atrial tachyarrhythmia was achieved in 69% patients in group 1% and 76% patients in group 2 (HR 0.7, 95% CI: 0.3–1.7). Conclusion: It is unknown whether empirical addition of SVC isolation to PVI improves freedom of recurrence for the treatment of recurrent PAF after previous PVI. Given the small study population, the addition of SVC isolation requires further investigation in a larger randomized trial.
- 23 May 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (8) , 1733-1742
Prospective Evaluation of Superior Vena Cava Isolation as an Adjunct to Pulmonary Vein Re‐Isolation During Paroxysmal Atrial Fibrillation Repeat Procedures
Background: The superior vena cava (SVC) is a prominent non‐pulmonary vein trigger of atrial fibrillation (AF). Its isolation has been shown to be effective in paroxysmal AF (PAF) originating from SVC. Objective: In this study, focusing on repeat procedures for recurrent PAF post‐PVI, we aimed to evaluate the added value of empirical SVC isolation to PV antral re‐isolation, when at least one PV reconnection is demonstrated. Methods: Patients with recurrent PAF referred for redo procedures, and exhibiting PV reconnection, were randomly assigned to undergo either PVI alone (group 1) or PVI and SVC isolation (group 2). The primary outcome was the recurrence rate at 1‐year while procedural time, fluoroscopy time, complications rate, and the presence of scar during LA mapping were secondary outcomes. Results: Eighty‐two patients were randomized in the study (39 in group 1 and 43 in group 2). The median age was 65 ± 9 in group 1 and 62 ± 11 in group 2 ( p = 0.3). The time from first AF episode to the repeat procedure was 76 and 52 months, respectively ( p = 0.7). 31 patients in group 1 and 35 patients in group 2 had more than one reconnected vein. There were no significant differences in procedural and fluoroscopy times between groups. At 12‐months, freedom from atrial tachyarrhythmia was achieved in 69% patients in group 1% and 76% patients in group 2 (HR 0.7, 95% CI: 0.3–1.7). Conclusion: It is unknown whether empirical addition of SVC isolation to PVI improves freedom of recurrence for the treatment of recurrent PAF after previous PVI. Given the small study population, the addition of SVC isolation requires further investigation in a larger randomized trial.
- 1 November 2024
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 17 (11) , e013102
Atrial Topology for a Unified Understanding of Typical and Atypical Flutter
BACKGROUND: Macroreentry stands as the predominant mechanism of typical and atypical flutter. Despite advances in mapping, many aspects of macroreentrant atrial tachycardia remain unsolved. In this translational study, we applied principles of topology to understand the activation patterns, entrainment characteristics, and ablation responses in a large clinical macroreentrant atrial tachycardia database. METHODS: Because the atrium can be topologically seen as a closed sphere with holes, we used a computational fixed spherical mesh model with a finite number of holes to induce and analyze macroreentrant atrial tachycardia. The ensuing insights were used to interpret high-density activation maps, postpacing interval-tachycardia cycle length values (difference between postpacing interval and tachycardia cycle length), and ablation response in 131 cases of typical and atypical flutter (n=106 left atrium, n=25 right atrium). RESULTS: Modeling of macroreentrant atrial tachycardia revealed that reentry on closed surfaces consistently manifests itself as paired rotation and that an odd number of critical boundaries is mathematically impossible. Together with mathematical confirmation by the index theorem, this led to a unifying construct that could explain the number of loops, difference between postpacing interval and tachycardia cycle length values, and ablation outcomes (termination, no change, or prolongation in tachycardia cycle length) in all 131 cases. CONCLUSIONS: Combining topology with the index theorem offers a novel and cohesive framework for understanding and managing typical and atypical flutter.
- 1 November 2024
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 17 (11) , e013102
Atrial Topology for a Unified Understanding of Typical and Atypical Flutter
BACKGROUND: Macroreentry stands as the predominant mechanism of typical and atypical flutter. Despite advances in mapping, many aspects of macroreentrant atrial tachycardia remain unsolved. In this translational study, we applied principles of topology to understand the activation patterns, entrainment characteristics, and ablation responses in a large clinical macroreentrant atrial tachycardia database. METHODS: Because the atrium can be topologically seen as a closed sphere with holes, we used a computational fixed spherical mesh model with a finite number of holes to induce and analyze macroreentrant atrial tachycardia. The ensuing insights were used to interpret high-density activation maps, postpacing interval-tachycardia cycle length values (difference between postpacing interval and tachycardia cycle length), and ablation response in 131 cases of typical and atypical flutter (n=106 left atrium, n=25 right atrium). RESULTS: Modeling of macroreentrant atrial tachycardia revealed that reentry on closed surfaces consistently manifests itself as paired rotation and that an odd number of critical boundaries is mathematically impossible. Together with mathematical confirmation by the index theorem, this led to a unifying construct that could explain the number of loops, difference between postpacing interval and tachycardia cycle length values, and ablation outcomes (termination, no change, or prolongation in tachycardia cycle length) in all 131 cases. CONCLUSIONS: Combining topology with the index theorem offers a novel and cohesive framework for understanding and managing typical and atypical flutter.
- Open Access
- 1 October 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (10)
Evaluation of posterior mitral isthmus ablation in the absence of a vein of Marshall
Achieving acute and durable mitral isthmus (MI) block remains challenging using radiofrequency (RF) catheter ablation alone. Vein of Marshall (VoM) ethanolization results in chemical damage along the MI resulting in the creation of a durable transmural lesion with a very high rate of procedural block. However, no studies have systematically assessed the efficacy of MI ablation alone when no anatomical VoM is present. Thirty seven patients without VoM evidenced after careful angiographic examination were included. Ablation parameters and result were compared with a matched control group in whom the posterior MI line was performed without assessing the presence of the VoM. Mitral isthmus block was achieved in 36 out of 37 patients without VoM (97%), with endocardial ablation only in 5/37 (14%) and combined endocardial and coronary sinus ablation in 32/37 patients (86%). There was a significant difference in the occurrence of block between patients without a VoM and the control group (97.3% vs. 65% respectively, P < 0.01), with a trend towards less needed RF {26 [interquartile range (IQR) 20–38] vs. 29 [IQR 19–40] tags [P = 0.8], 611 [IQR 443–805] vs. 746 [IQR 484–1193] seconds [P = 0.08]}. The absence of a VoM is associated with a very high rate of procedural block during posterior MI ablation. The higher rate of MI block in this specific population would also suggest the crucial role of the VoM (when present) in resistant MI block.
- 1 October 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (10)
Open AccessEvaluation of posterior mitral isthmus ablation in the absence of a vein of Marshall
Achieving acute and durable mitral isthmus (MI) block remains challenging using radiofrequency (RF) catheter ablation alone. Vein of Marshall (VoM) ethanolization results in chemical damage along the MI resulting in the creation of a durable transmural lesion with a very high rate of procedural block. However, no studies have systematically assessed the efficacy of MI ablation alone when no anatomical VoM is present. Thirty seven patients without VoM evidenced after careful angiographic examination were included. Ablation parameters and result were compared with a matched control group in whom the posterior MI line was performed without assessing the presence of the VoM. Mitral isthmus block was achieved in 36 out of 37 patients without VoM (97%), with endocardial ablation only in 5/37 (14%) and combined endocardial and coronary sinus ablation in 32/37 patients (86%). There was a significant difference in the occurrence of block between patients without a VoM and the control group (97.3% vs. 65% respectively, P < 0.01), with a trend towards less needed RF {26 [interquartile range (IQR) 20–38] vs. 29 [IQR 19–40] tags [P = 0.8], 611 [IQR 443–805] vs. 746 [IQR 484–1193] seconds [P = 0.08]}. The absence of a VoM is associated with a very high rate of procedural block during posterior MI ablation. The higher rate of MI block in this specific population would also suggest the crucial role of the VoM (when present) in resistant MI block.
- Open Access
- 1 October 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (10)
Intravascular haemolysis and acute kidney injury following atrial fibrillation ablation: a report using two different systems for pulsed field ablation
Pulmonary vein isolation (PVI) is an established cornerstone of rhythm management in patients with atrial fibrillation (AF).1,2 Before pulsed field ablation (PFA), PVI lesions were solely created by thermal radiofrequency (RF), cryo, or laser energy. Pulsed field ablation, resulting in irreversible electroporation of cell membranes to which cardiac muscle is especially sensible, is the first non-thermal energy that provides effective PVI with good durability, including non-inferiority when compared with RF.2,3
- 1 October 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (10)
Open AccessIntravascular haemolysis and acute kidney injury following atrial fibrillation ablation: a report using two different systems for pulsed field ablation
Pulmonary vein isolation (PVI) is an established cornerstone of rhythm management in patients with atrial fibrillation (AF).1,2 Before pulsed field ablation (PFA), PVI lesions were solely created by thermal radiofrequency (RF), cryo, or laser energy. Pulsed field ablation, resulting in irreversible electroporation of cell membranes to which cardiac muscle is especially sensible, is the first non-thermal energy that provides effective PVI with good durability, including non-inferiority when compared with RF.2,3
- Open Access
- 28 February 2024
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 4 (2) , oeae014
Procedural performance and outcome after pulsed field ablation for pulmonary vein isolation: comparison with a reference radiofrequency database
Pulsed field ablation (PFA) is a promising ablation technique for pulmonary vein isolation (PVI) with appealing advantages over radiofrequency (RF) including speed, tissue selectivity, and the promise of enhanced durability. In this study, we determine the procedural performance, efficacy, safety, and durability of PFA and compare its performance with a dataset of optimized RF ablation. After propensity score matching, we compared 161 patients who received optimized RF-guided PVI in the PowerPlus study (CLOSE protocol) with 161 patients undergoing PFA-guided PVI for paroxysmal or persistent atrial fibrillation (AF; pentaspline basket catheter). The median age was 65 years with 78% paroxysmal AF in the PFA group (comparable characteristics in the RF group). Pulsed field ablation–guided PVI was obtained in all patients with a procedure time of 47 min (vs. 71 min in RF, P < 0.0001) and a fluoroscopy time of 15 min (vs. 11 min in RF, P < 0.0001). One serious adverse event [transient ischaemic attack] occurred in a patient with thrombocytosis (0.6 vs. 0% in RF). During the 6-month follow-up, 24 and 27 patients experienced a recurrence with 20 and 11 repeat procedures in the PFA and the RF groups, respectively (P = 0.6 and 0.09). High-density mapping revealed a status of 4 isolated veins in 7/20 patients in the PFA group and in 2/11 patients in the RF group (35 vs. 18%, P = 0.3). Pulsed field ablation fulfils the promise of offering a short and safe PVI procedure, even when compared with optimized RF in experienced hands. Pulmonary vein reconnection is the dominant cause of recurrence and tempers the expectation of a high durability rate with PFA.
- 28 February 2024
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 4 (2) , oeae014
Open AccessProcedural performance and outcome after pulsed field ablation for pulmonary vein isolation: comparison with a reference radiofrequency database
Pulsed field ablation (PFA) is a promising ablation technique for pulmonary vein isolation (PVI) with appealing advantages over radiofrequency (RF) including speed, tissue selectivity, and the promise of enhanced durability. In this study, we determine the procedural performance, efficacy, safety, and durability of PFA and compare its performance with a dataset of optimized RF ablation. After propensity score matching, we compared 161 patients who received optimized RF-guided PVI in the PowerPlus study (CLOSE protocol) with 161 patients undergoing PFA-guided PVI for paroxysmal or persistent atrial fibrillation (AF; pentaspline basket catheter). The median age was 65 years with 78% paroxysmal AF in the PFA group (comparable characteristics in the RF group). Pulsed field ablation–guided PVI was obtained in all patients with a procedure time of 47 min (vs. 71 min in RF, P < 0.0001) and a fluoroscopy time of 15 min (vs. 11 min in RF, P < 0.0001). One serious adverse event [transient ischaemic attack] occurred in a patient with thrombocytosis (0.6 vs. 0% in RF). During the 6-month follow-up, 24 and 27 patients experienced a recurrence with 20 and 11 repeat procedures in the PFA and the RF groups, respectively (P = 0.6 and 0.09). High-density mapping revealed a status of 4 isolated veins in 7/20 patients in the PFA group and in 2/11 patients in the RF group (35 vs. 18%, P = 0.3). Pulsed field ablation fulfils the promise of offering a short and safe PVI procedure, even when compared with optimized RF in experienced hands. Pulmonary vein reconnection is the dominant cause of recurrence and tempers the expectation of a high durability rate with PFA.
- Open Access
- 31 October 2023
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 10 (1) , 72-75
Interaction between left bundle branch area pacing lead and defibrillator lead: A case report
- 31 October 2023
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 10 (1) , 72-75
Open AccessInteraction between left bundle branch area pacing lead and defibrillator lead: A case report
- 13 June 2022
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 78 (2) , 135-139
Changes in lipid lowering medication and lipid levels over time in patients with stable coronary artery disease
To provide longitudinal data on the evolution of lipid levels and the intake of lipid-lowering therapies in patients with stable coronary artery disease.Single-centre retrospective study with inclu...
- 13 June 2022
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 78 (2) , 135-139
Changes in lipid lowering medication and lipid levels over time in patients with stable coronary artery disease
To provide longitudinal data on the evolution of lipid levels and the intake of lipid-lowering therapies in patients with stable coronary artery disease.Single-centre retrospective study with inclu...